Skip to content

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04313140
Acronym
MR3TGLIOBIOPSY
Enrollment
500
Registered
2020-03-18
Start date
2021-02-22
Completion date
2029-02-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence Algorithms, Clinical, Development of the Virtual Biopsy, Radiological, Tumor Grade

Brief summary

Glioma is a tumor of the central nervous system. These lesions are sorted with the WHO ranking regarding the tumoral oncotype. The tumoral MRI assessment is the first step before any medical decision. Currently, only anatomical biopsy can give the tumor grade definition and help to define the most adapted treatment.

Interventions

DIAGNOSTIC_TESTDiagnostic test

The intervention occurs only one time (for 2h30), the MRI examination is divided as follow: * Cinicial MRI (50 minutes) * Research MRI (Phosphorus Spectroscopy, Sodium Imaging)

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age≥ 18 years, * Patient with suspected glioma with prior imaging * Subject free, with legal protection guardianship or curatorship; * Enrollment in the French Social Security system; * Informed consent signed by the patient

Exclusion criteria

* Any contraindication to an MRI examination * Legal protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, persons residing in a health or social establishment, adults under legal protection and finally patients in emergency situations * Pregnant or lactating women, women of childbearing age who do not have effective contraception

Design outcomes

Primary

MeasureTime frameDescription
Validation of the virtual biopsy in the context of gliomas through the use of statistical learning algorithms (artificial intelligence) compared to the biopsy.The MRI examination (for 2 hours 30 minutes)Evaluate the diagnostic capabilities of artificial intelligence algorithms for virtual biopsy based on sensitivity and specificity

Countries

France

Contacts

CONTACTRémy GUILLEVIN, Pr
remy.guillevin@chu-poitiers.fr05.49.44.45.42

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026